Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 163   

Articles published

NVS 82.73 +0.22 (0.27%)
price chart
Will Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) And Novartis AG (ADR ...
It is not clear whether Teva's Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Novartis AG (ADR)(NYSE:NVS) are trying to fend off copy cats.
Novartis AG (ADR) Aiming to Target Biosimilar Market by 2020
By 2020, Novartis AG (NYSE:NVS) plans to launch a number of biosimilar versions of the blockbuster drugs in order to enter multiple therapeutic markets.
Novartis AG (ADR) (NYSE:NVS) Stops Phase III Trial of Arzerra for Pemphigus ...
Seven months after acquiring the autoimmune indications rights to Arzerra from GlaxoSmithKline plc (ADR) (NYSE:GSK), Novartis AG (ADR) (NYSE:NVS) has ended the Phase III trial of Genmab A/S' (CPH:GEN) drug on those suffering from pemphigus ...
What Next for Novartis AG (ADR) After Today's Gap Down?
The stock of Novartis AG (ADR) (NYSE:NVS) gapped down by $0.45 today and has $72.47 target or 6.00% below today's $77.10 share price.
Analysts Ratings on Novartis AG (ADR) (NYSE:NVS)
The mean price target for the shares of Novartis AG (ADR) (NYSE:NVS)is at $92.50 while the highest price target suggested by the analysts is $115.00 and low price target is $81.00.
HC Stocks Alerts: Shire PLC (ADR) (NASDAQ:SHPG), Novartis AG (ADR) (NYSE:NVS)  share market updates (press release)
What Analyst's have to say about Novartis AG (ADR) (NYSE:NVS)
The mean price target for the shares of Novartis AG (ADR) (NYSE:NVS)is at $92.50 while the highest price target suggested by the analysts is $115.00 and low price target is $81.00.
Novartis AG (ADR) First-Quarter Earnings: What to Expect?
Novartis AG (ADR) (NYSE:NVS) is set to announce its financial results for the first quarter of 2016 (1Q) on Thursday, April 21.
Amgen, Inc. (NASDAQ:AMGN) Has Sued Novartis' AG (ADR) (NYSE:NVS) Sandoz Unit ...
Top-selling anti-inflammatory drug Enbrel from Amgen, Inc. (NASDAQ:AMGN) is facing steep competition from biosimilars that are hitting the market at a very rapid speed.
Amgen Inc to Face Off Pfizer & Novartis to Save Key Drugs  Bidness ETC
Brexit: Shockwaves to AstraZeneca, Novartis, GlaxoSmithKline
The astonishing verdict by the UK people to cut ties with the European Union (EU) has put pharmaceutical companies such as AstraZeneca plc (NYSE:AZN), Novartis, and GlaxoSmithKline in a rollercoaster as the European Medicines Agency (EMA) has to be ...
HC Stocks Vigilant: CIGNA Corporation (NYSE:CI), Novartis AG (ADR) (NYSE:NVS)
Shares of Novartis AG (ADR) (NYSE:NVS) ended Tuesday session in green amid volatile trading. The shares closed up +0.79 points or 1.00% at $79.46 with 2.43 million shares getting traded.